Weight-based dosing of Yttrium 90 ibritumomab tiuxetan in patients with relapsed or refractory B-cell non-Hodgkin lymphoma.

Source:http://linkedlifedata.com/resource/pubmed/id/18021468

Download in:

View as

General Info

PMID
18021468